PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Edward B. Garon, MD, MS - Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet Needs in NSCLC Without Actionable Mutations
Visit https://www.peervoice.com/RHS860 to view the entire programme with slides. After completing “Edward B. Garon, MD, MS - Abundance of Choice at First Line, Lack of Options Beyond: Addressing Unmet Needs in NSCLC Without Actionable Mutations”, participants will be able to: Identify current and anticipated strategies for managing NSCLC without actionable oncogenic driver mutations, including combination approaches with immunotherapies and other agents; and Assess the clinical relevance of safety and efficacy data from randomized clinical trials evaluating novel treatment approaches in advanced NSCLC without actionable genomic alterations.